Symptomatic cerebrospinal fluid HIV-1 escape with no resistance-associated mutations following low-level plasma viremia.

about

Symptomatic cerebrospinal fluid HIV-1 escape with no resistance-associated mutations following low-level plasma viremia.

Item

http://www.wikidata.org/entity/Q47564644

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Symptomatic cerebrospinal flui ...... wing low-level plasma viremia.

@en

Symptomatic cerebrospinal flui ...... wing low-level plasma viremia.

@nl

type

Item

label

Symptomatic cerebrospinal flui ...... wing low-level plasma viremia.

@en

Symptomatic cerebrospinal flui ...... wing low-level plasma viremia.

@nl

prefLabel

Symptomatic cerebrospinal flui ...... wing low-level plasma viremia.

@en

Symptomatic cerebrospinal flui ...... wing low-level plasma viremia.

@nl

P1476

Symptomatic cerebrospinal flui ...... owing low-level plasma viremia

@en

P2093

Alessandra Romito

http://www.w3.org/2001/XMLSchema#string

Andrea Calcagno

http://www.w3.org/2001/XMLSchema#string

Arianna Sala

http://www.w3.org/2001/XMLSchema#string

Caterina Martini

http://www.w3.org/2001/XMLSchema#string

Daniele Imperiale

http://www.w3.org/2001/XMLSchema#string

Giovanni Di Perri

http://www.w3.org/2001/XMLSchema#string

Jessica Cusato

http://www.w3.org/2001/XMLSchema#string

Laura Pesci Kincer

http://www.w3.org/2001/XMLSchema#string

Micol Ferrara

http://www.w3.org/2001/XMLSchema#string

Sabrina Audagnotto

http://www.w3.org/2001/XMLSchema#string

P2860

The NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytes

Antibodies to myelin oligodendrocyte glycoprotein in HIV-1 associated neurocognitive disorder: a cross-sectional cohort study.

HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment

Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir.

Primer ID Validates Template Sampling Depth and Greatly Reduces the Error Rate of Next-Generation Sequencing of HIV-1 Genomic RNA Populations.

Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load.

Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy.

Immune activation in the central nervous system throughout the course of HIV infection.

Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: A Longitudinal Study.

Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia.

P2888

s13365-017-0605-1

P304

132-136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13365-017-0605-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mattia Trunfio

P577

2017-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29243133

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid